What research-use-only labeling is, what a supplier's RUO disclaimer and purchaser gate do, how we check them, and why health claims beside RUO are flagged.
Every supplier in our data set sells materials under some version of a research-use-only label, and most display a disclaimer in the footer saying so. Buyers see the phrase so often that it stops meaning anything, and suppliers sometimes present it as if it were a certification. It is neither decoration nor a license. This guide explains what research-use-only labeling is, what a supplier’s disclaimer and purchaser gate are supposed to accomplish, how we check for both, and why a product page that makes health claims above an RUO footer is making two statements that cannot both be true.
What research use only labeling is
“Research use only” is a labeling category, not an approval. It states the seller’s intended market: laboratories conducting research. Materials labeled this way are, by the seller’s own statement, not intended for any use outside that context. The standard wording on vials and product pages runs along the lines of “for laboratory research use only; not for human or veterinary use,” and some suppliers add “not for diagnostic or clinical use.”
Three things the label is not:
- It is not a regulatory status granted by an agency. No body reviews and approves a product as RUO. The seller applies the label.
- It is not a quality statement. RUO says nothing about purity, identity or testing. A certificate of analysis addresses those; the label does not.
- It is not a shield that redefines the product. Under the Federal Food, Drug, and Cosmetic Act, whether a product is a drug turns on its intended use, and regulators read intended use from everything the seller publishes, not from the footer alone.
What the disclaimer and the purchaser gate are for
A supplier that takes the RUO category seriously typically has two visible controls.
The disclaimer is the written statement, in the footer, on product pages and ideally on the label itself, that products are for laboratory research only. Its job is to define the intended market in the seller’s own words.
The qualified-purchaser gate is a step in the buying process, a checkbox at checkout, a pop-up on first visit, or an account registration that asks the buyer to affirm they are purchasing on behalf of a laboratory or research institution and are not a consumer. Its job is to document that the buyer was told the intended market and agreed to it.
Both controls are statements of intent. Their value depends entirely on whether the rest of the site agrees with them. A disclaimer that says “research only” beneath a product page describing effects on the body is contradicted by its own page. A purchaser gate that asks the buyer to confirm laboratory status while the site’s blog publishes consumer guidance is a formality.
| Control | What it is | What it establishes when the site is consistent | What it establishes when the site contradicts it |
|---|---|---|---|
| RUO disclaimer in footer | Site-wide statement of intended market | Supplier has stated its intended market | Little; regulators and readers weigh the product pages, not the footer |
| RUO statement on each product page | Per-product restatement | Intended market is stated where the buyer decides | Direct contradiction if the same page carries health claims |
| RUO on the vial label | Physical labeling | The stated market travels with the product | Label and marketing disagree |
| Qualified-purchaser gate | Buyer affirmation at entry or checkout | Supplier documented the buyer’s stated status | A click-through with no effect on what the site says elsewhere |
How we check for RUO labeling
Our records carry a field for whether an RUO disclaimer is present, set to true, false or unknown from the live site at fetch time. As of October 2026, 45 of the 62 suppliers in our data set show a disclaimer and 17 are recorded as unknown, in most cases because the site did not load or blocked our fetch. We also note in a supplier’s green flags when the disclaimer is present and in its red flags when product pages carry health claims.
What we look at, in order:
- The footer, for a site-wide RUO statement.
- A sample of product pages, for a per-product RUO statement and for any claims about effects on the body, on health, or on named conditions.
- The entry and checkout flow, for a purchaser gate and its wording.
- The blog and FAQ pages, for content aimed at consumers rather than laboratories.
- The vial or label images, where published, for RUO wording on the product itself.
A supplier with a clear disclaimer, product pages that stay within the research framing and a purchaser gate earns the RUO credit in our transparency factor. A supplier with no disclaimer at all earns none. A supplier with the disclaimer and health claims on the same pages earns the credit for presence and a red flag for the contradiction, and the report says so in both places. We do not repeat the claims; we note that they are there.
Why a health claim next to an RUO footer is a contradiction
The logic is not ours; it is the regulator’s, and it is in every warning letter in our data set.
The FDA reads intended use from the supplier’s own words: product descriptions, blog posts, social media, customer-facing emails. If those words describe effects on the body or on disease, the agency concludes the product is intended as a drug. The footer stating “research use only” does not override the product page, because the agency is asking what the seller intends the product to be used for, and the product page is where the seller answered.
That is why a supplier cannot have both. Either the products are for laboratory research, in which case the product pages have nothing to say about effects in people, or the product pages make such claims, in which case the RUO footer describes a market the supplier is not actually selling to. Seven suppliers in our data set received FDA warning letters while displaying RUO language. In each letter the agency quoted the supplier’s own marketing and stated that the disclaimer did not change its conclusion. Our guide to warning letters walks through that structure.
For a buyer, the contradiction is a reliability signal independent of the regulatory question. A supplier whose footer and product pages disagree has shown that its compliance statements are not controlling what it publishes. That is a fact about the supplier’s practices, and it is the kind of fact our reports exist to record.
What a consistent RUO site looks like
The suppliers that score best on this factor share a visible pattern:
- The disclaimer appears in the footer, on every product page and on the label.
- Product pages describe the material: name, sequence or coded name as the supplier lists it, quantity, format, lot, and a link to the certificate. They do not describe effects.
- A purchaser gate appears before checkout and its wording matches the disclaimer.
- Blog and FAQ content is about the supplier’s documents, testing and policies, not about outcomes.
- Marketing emails and social accounts follow the same line as the site.
None of this is hard to do. It is a choice about what to publish, and the suppliers that make it consistently are easier to verify on every other factor as well, because the same discipline shows up in their certificate libraries and their legal footers.
How to read the label as a buyer
When you land on a supplier’s site, read the footer, then open a product page and read it against the footer. If the two agree, the supplier has at least stated a consistent position, and you can move on to checking its certificates and its legal identity. If they disagree, you have learned something about how the supplier operates before you have looked at a single certificate. Our reports record both outcomes in plain words, and our watchlist notes suppliers where the contradiction has already drawn a regulator’s attention.